Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine plus carbamazepine versus placebo plus carbamazepine for manic or mixed episodes in bipolar I disorder
2004-000589-11Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder, mania and bipolar disorder (BD) comparing Olanzapine plus carbamazepine with Placebo plus carbamazepine (2 arms). Started Aug 2004; status: completed.
02
Drugs
olanzapinecarbamazepine
03
Conditions
bipolar I disordermaniabipolar disorder (BD)
Beyond the preview
Go deeper on 2004-000589-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000589-11.